Gram-negative bacteria with a spiral structure called helicobacter cause ulceration by generating chronic inflammation and infection in the stomach and duodenum. 90% of individuals with duodenal ulcers and 50-80% of patients with stomach ulcers had H. pylori in their systems. One in six people with H. pylori infection are predicted to eventually develop peptic ulcer disease. The majority of infected people have minor symptoms like occasional belching, bloating, nausea, vomiting, and abdominal pain, while the majority also experience serious symptoms like abdominal pain, peptic ulcers, poor breath, etc. Both invasive tests, which need samples of the gastric mucosa taken during an endoscopy and utilized for a biopsy, and non-invasive tests, which only need blood or stool samples, can be used to diagnose helicobacter infection.
Analysis
of the market for Helicobacter Pylori
Diagnostics Market.
A spiral-shaped gram-negative bacteria called Helicobacter causes chronic
inflammation and infection in the stomach and duodenum, which eventually
results in ulceration.
A
gram-negative aerobic bacteria commonly found in the stomach is called
Helicobacter pylori (H. pylori). While it maintains the ecology of the stomach,
it can also infect the inner stomach lining. Infection in the small intestine,
gastritis, duodenal ulcers, stomach cancer, and gastric ulcers can all be
brought on by the bacterium. The need for Helicobacter
Pylori Diagnostics Market tools has grown as a result of this.
Infections with Helicobacter Pylori Diagnostics Market are particularly common in underdeveloped countries. The spread of these illnesses can be related to a number of important conditions, such as an inadequate water supply, poor sanitation, a congested population, and poor personal hygiene. One of the things driving the Helicobacter pylori diagnostics market's rise is the increasing public awareness of H. pylori infections in the population.
Key Players
Thermo Fisher Scientific,
Inc., Bio-Rad Laboratories, Inc., Diasorin S.P.A., Quidel Corporation, F.
Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.), Meridian Bioscience,
Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and
Halyard Health, Inc. are some of the major companies active in the global
Helicobacter pylori diagnostics market
Comments
Post a Comment